FDA Inspection 782687 — Claris Lifesciences Inc

Claris Lifesciences Inc — FEI 3007003961

The FDA completed an inspection of Claris Lifesciences Inc on May 18, 2012 in North Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
May 18, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
North Brunswick, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.